HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Role of sphingosine 1-phosphate in the pathogenesis of Sjögren's syndrome.

Abstract
Primary Sjögren's syndrome (SS) is an autoimmune disease characterized by inflammatory mononuclear cell infiltration and destruction of epithelial cells of lacrimal and salivary glands. Sphingosine 1-phosphate (S1P) and signaling through its receptor S1P(1) have been implicated in many critical cellular events including inflammation, cancer, and angiogenesis. This study was undertaken to examine the role of S1P(1) signaling in the pathogenesis of primary SS. S1P(1) and sphingosine kinase 1, which converts sphingosine to S1P, were detected in the cytoplasm of inflammatory mononuclear cells, vascular endothelial cells, and epithelial cells in all labial salivary glands by immunohistochemistry. The expression of S1P(1) in inflammatory mononuclear cells was enhanced in advanced stages of primary SS. S1P enhanced proliferation and IFN-gamma production by CD4(+) T cells. The enhancing effect of S1P on IFN-gamma production by CD4(+) T cells was stronger in patients with primary SS than in healthy controls. S1P also enhanced Fas expression and Fas-mediated caspase-3 induction in salivary gland epithelial cells. IL-6 expression was detected in the cytoplasm of inflammatory mononuclear cells and ductal epithelial cells and was enhanced in advanced stages of primary SS. Furthermore, both IFN-gamma and S1P augmented IL-6 secretion by salivary gland epithelial cells. These effects of S1P were inhibited by pretreatment of pertussis toxin. Our data reveal that S1P(1) signaling may modulate the autoimmune phenotype of primary SS by the action of immune as well as epithelial cells.
AuthorsMasahiro Sekiguchi, Tsuyoshi Iwasaki, Masayasu Kitano, Hideki Kuno, Naoaki Hashimoto, Yutaka Kawahito, Masayuki Azuma, Timothy Hla, Hajime Sano
JournalJournal of immunology (Baltimore, Md. : 1950) (J Immunol) Vol. 180 Issue 3 Pg. 1921-8 (Feb 01 2008) ISSN: 0022-1767 [Print] United States
PMID18209090 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Interleukin-6
  • Lysophospholipids
  • RNA, Messenger
  • Receptors, Lysosphingolipid
  • fas Receptor
  • sphingosine 1-phosphate
  • Interferon-gamma
  • Caspase 3
  • Sphingosine
Topics
  • Adult
  • Autoimmune Diseases (immunology, pathology)
  • CD4-Positive T-Lymphocytes (drug effects, immunology)
  • Caspase 3 (metabolism)
  • Dendritic Cells (immunology)
  • Epithelial Cells (drug effects, metabolism)
  • Female
  • Humans
  • Interferon-gamma (metabolism)
  • Interleukin-6 (metabolism)
  • Lymphocyte Activation
  • Lysophospholipids (analysis, metabolism, pharmacology)
  • Male
  • Middle Aged
  • RNA, Messenger (metabolism)
  • Receptors, Lysosphingolipid (analysis, metabolism)
  • Salivary Glands (chemistry, immunology, pathology)
  • Sjogren's Syndrome (immunology, pathology)
  • Sphingosine (analogs & derivatives, analysis, metabolism, pharmacology)
  • fas Receptor (genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: